Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
11.35
+0.72 (6.77%)
At close: Jul 16, 2026, 4:00 PM EDT
11.55
+0.20 (1.76%)
Pre-market: Jul 17, 2026, 4:36 AM EDT
Adlai Nortye Revenue
In the year 2025, Adlai Nortye had annual revenue of $5.00M. Adlai Nortye had revenue of $5.00M in the half year ending December 31, 2025.
Revenue (ttm)
$5.00M
Revenue Growth
n/a
P/S Ratio
90.80
Revenue / Employee
$45,872
Employees
109
Market Cap
454.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 45.73M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 227.18M |
| Sutro Biopharma | 99.61M |
| Prothena Corporation | 57.94M |
| vTv Therapeutics | 36.84M |
| C4 Therapeutics | 34.86M |
| Prelude Therapeutics | 16.72M |
| Abeona Therapeutics | 14.54M |
ANL News
- 1 day ago - Adlai Nortye doses first patient in AN9025 trial - TheFly
- 1 day ago - Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025 - GlobeNewsWire
- 4 days ago - Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists - GlobeNewsWire
- 25 days ago - Cantor starts Adlai Nortye at Overweight, sees 180% upside - TheFly
- 25 days ago - Adlai Nortye initiated with an Overweight at Cantor Fitzgerald - TheFly
- 6 weeks ago - Adlai Nortye Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Adlai Nortye initiated with an Outperform at Oppenheimer - TheFly
- 2 months ago - Adlai Nortye initiated with a Buy at JonesResearch - TheFly